As of Mar 24
| +1.05 / +2.77%|
The 11 analysts offering 12-month price forecasts for Ionis Pharmaceuticals Inc have a median target of 47.00, with a high estimate of 66.00 and a low estimate of 17.00. The median estimate represents a +20.57% increase from the last price of 38.98.
The current consensus among 13 polled investment analysts is to Hold stock in Ionis Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.